Am J Transplant, Volume 16, Suppl 3 Archives - Page 148 of 180 - ATC Abstracts

2016 American Transplant Congress
Center Level Analysis of Changes in Living Donor Transplant Rates in the United States.
D. Keith, A. Nishio Lucar, G. Vranic.
Medicine, Division of Nephrology, University of Virginia, Charlottesville, VA.
Rates of living donor kidney transplantation have been declining in the United States since 2003. Tremendous variation exists in the rate of living donor transplantation…
2016 American Transplant Congress
Renal Allograft Outcomes with Renal Artery Angioplasty and/or Stenting in Transplant Renal Artery Stenosis.
E. Tantisattamo,¹ A. Chokechanachaisakul,² S. Pitukweerakul,³ P. Ratanasrimetha,⁴ A. Shetty,² O. Traitanon,⁵ L. Gallon.²
¹Oakland University William Beaumont School of Medicine, Royal Oak, MI; ²Northwestern University, Chicago, IL; ³Presence St. Francis Hospital, Evanston, IL; ⁴Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand; ⁵Thammasart University Hospital, Pathumthani, Thailand.
Background: The renal allograft function and blood pressure (BP) control after renal artery angioplasty±stenting for transplant renal artery stenosis (TRAS) is unclear. We aim to…
2016 American Transplant Congress
PD-L1/PD-L2-Expressing B-1a Cells Inhibit Allo-Reactive T Cells in Mice.
T. Hirose,^1,2 Y. Tanaka,¹ H. Ohdan.¹
¹Transplant Surgery, Hiroshima University, Hiroshima, Japan; ²Urology, Hokkaido University, Sapporo, Hokkaido, Japan.
Donor lymphocyte infusion (DLI) induces donor-specific hypo responsiveness or immune-tolerance among allo-reactive T cells in different organ transplantation models. However, the optimal cell source or…
2016 American Transplant Congress
Sequential Analysis of Donor-Specific Antibodies and Pathological Findings Using Intravenous Immunoglobulin in a Highly Sensitized Rat Kidney Transplant Model.
Y. Sawada,¹ K. Omoto,² N. Kohei,⁴ K. Kawanishi,³ M. Okumi,² H. Ishida,² T. Kazunari.²
¹Urology, Fukushima Rosai Hospital, Iwaki, Japan; ²Urology, Tokyo Women's Medical University, Tokyo, Japan; ³Pathology, Tokyo Women's Medical University, Tokyo, Japan; ⁴Urology, Shizuoka General Hospital, Shizuoka, Japan.
Intravenous immunoglobulin (IVIG) has evolved widespread use for treatment of acute antibody-mediated rejection (AAMR) and desensitization in highly HLA-sensitized patients. However, sequential change of the…
2016 American Transplant Congress
Impact of Immunosuppressants on Inducing Regulatory T Cells in Human Allo-Immune Responses.
Y. Tanaka, H. Ohdan.
Transplant Surgery, Hiroshima University, Hiroshima, Japan.
A better understanding of cytokine signaling pathways involving transcription factors of the STAT family in T cells responding to allostimulation will improve interpretation of immune-regulatory…
2016 American Transplant Congress
Long Term Results on Pancreas Transplant Beyond the Standard Indications, at a Single Center.
D. Ramisch,¹ N. Aguirre,¹ F. Moss,² P. Farinelli,¹ R. Fortunato,² L. Gutierrez,² P. Barros Schelotto,¹ H. Fraguas,³ P. Raffaele,² G. Gondolesi.¹
¹Instuto de Transplante Multiorganico, Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina; ²Unidad de Trasplante Renal y Nefrologia, Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina; ³Servicio de Cirugia Cardiovascular, Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina.
Introduction: Simultaneous kidney-pancreas (SKP) transplantation has become the best treatment option for patients with end stage renal disease (ESRD) and type 1 diabetes (T1D). In…
2016 American Transplant Congress
Outcomes with Steroids Alone for Biopsy-Proven Pancreas Transplant Rejection.
S. Salahuddin,¹ B. Astor,¹ S. Parajuli,¹ A. Djamali,¹ J. Odorico,² D. Mandelbrot.¹
¹Department of Nephrology, University of Wisconsin, Madison, WI; ²Department of Surgery, University of Wisconsin, Madison, WI.
There is little published data on the response of pancreas rejection to steroids alone. We reviewed 42 pancreas transplant recipients between 01/1997 and 12/2013 at…
2016 American Transplant Congress
Effect of Pylorus Preservation Procedure on Patient and Graft Outcome in Total Pancreatectomy with Islet Autotransplantation.
R. Shahbazov,¹ A. Dabous,² G. Yoshimatsu,² H. Fernandez,² G. Saracino,² B. Naziruddin,² N. Onaca,² P. Kim,² M. Levy.³
¹Department of Surgery, University of Virginia, Charlottsville, VA; ²Baylor Simmons Transplant Institute, Dallas, TX; ³Transplant Division, VCU Medical Center, Richmond, VA.
Introduction: Total pancreatectomy with islet autotransplantation (TPIAT) is an effective treatment to retain pancreatic endocrine function while alleviating intractable pain in Chronic Pancreatitis. The role…
2016 American Transplant Congress
Hospital Readmissions Following Incompatible Kidney Transplantation: A Multi-Center Study.
B. Orandi, E. King, X. Luo, S. Bae, B. Lonze, R. Montgomery, D. Segev.
Johns Hopkins, Baltimore.
Desensitization and incompatible live donor kidney transplantation (ILDKT) has improved survival vs. forgoing transplant or waiting for a compatible one. It is unknown if increased…
2016 American Transplant Congress
NEAD Chains Do Not Disadvantage Blood Type O, Black, or Highly Sensitized Patients.
M. Rees,¹ J. Roberts,² K. Lentine,³ A. Roth,⁴ A. Leichtman,⁵ H. Xiao,³ S. Rafizadeh,¹ E. Neidich,² M. Melcher.⁴
¹UT, Toledo; ²UCSF, SF; ³SLU, St Louis; ⁴Stanford, Palo Alto; ⁵Arbor Res, Ann Arbor.
Introduction: NEAD chains raised concern that wait-listed blood type (BT) O patients and racial minorities would be disadvantaged by allocation of a non-directed donor (NDD)…